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The non-structural protein 1 (nsp1) of porcine reproductive and respiratory syndrome virus is partly
responsible for inhibition of type I interferon (IFN) response by the infected host. By performing
alanine-scanning mutagenesis, we have identiﬁed amino acid residues in nsp1a and nsp1b (the
proteolytic products of nsp1) that when substituted with alanine(s) exhibited signiﬁcant relief of IFN-
suppression. A mutant virus (16-5A, in which residues 16–20 of nsp1b were substituted with alanines)
encoding mutant nsp1b recovered from infectious cDNA clone was shown to be attenuated for growth
in vitro and induced signiﬁcantly higher amount of type I IFN transcripts in infected macrophages. In
infected pigs, the 16-5A virus exhibited reduced growth at early times after infection but quickly
regained wild type growth properties as a result of substitutions within the mutated sequences. The
results indicate a strong selection pressure towards maintaining the IFN-inhibitory property of the
virus for successful propagation in pigs.
& 2012 Elsevier Inc. All rights reserved.Introduction
Porcine reproductive and respiratory syndrome (PRRS) is a
signiﬁcant animal disease affecting swine herds in all pork-
producing countries. Two major clinical manifestations of the
disease are late term reproductive failure in pregnant sows and
respiratory distress in young piglets as well as growing pigs. The
annual economic losses as a result of PRRS to the USA swine
industry alone has been estimated to be more than $660 million
(Miller, 2011). The recent large-scale outbreak of ‘‘high fever’’
disease in China in 2006 with unusually high mortality rate
further adds to the signiﬁcance of this swine pathogen (Tian
et al., 2007). The etiological agent of the disease is PRRS virus
(PRRSV), an enveloped positive-sense, single-stranded RNA virus
with a genome of 15 kb. PRRSV belongs to the family Arteriviridae
which, along with Coronaviridae and Roniviridae families, form the
order Nidovirales (Cavanagh, 1997). Other members of Arteriviridaell rights reserved.
nesota, Minneapolis,
obiology, Virginia-Maryland
ech, Blacksburg, VA 24060,families include equine arteritis virus (EAV), lactate dehydro-
genase-elevating virus (LDV) and simian hemorrhagic fever
virus (SHFV). The viral genome encodes 10 open reading frames
(ORFs)—ORF1a, ORF1b, ORF2a, ORF2b, ORF3, ORF4, ORF5a, ORF5,
ORF6 and ORF7. The ORF1a and ORF1b are translated to generate
polyproteins, which are processed by viral proteases to form 14
different non-structural proteins (nsps) (Fang and Snijder, 2010;
Snijder and Meulenberg, 1998). Several of the nsps have been
identiﬁed as integral members of viral replication and transcrip-
tion machinery while others might be involved in these processes
through their interaction with host cell factors (Beura et al., 2011;
Fang and Snijder, 2010). Furthermore, the nsps are also likely to
regulate viral pathogenesis through their involvement in modula-
tion of host innate immune response.
The type 1 interferon (IFN) constitutes a major player of the
host innate immune response system. Viral replication intermedi-
ates like double stranded RNA (dsRNA) are sensed by cytoplasmic
(RIG-I like helicases) as well as endosomal (Toll-like receptor 3,
TLR3) sensors, which trigger a complex signaling cascade (Bowie
and Unterholzner, 2008; Kawai and Akira, 2009). These signaling
events culminate in activation of several transcription factors
including interferon regulatory factor 3 (IRF3), nuclear factor
kappa B (NF-kB) and activating transcription factor-2 (ATF-2).
These transcription factors coordinately drive expression of type
1 IFN genes. Once secreted, IFNs bind to their cognate receptors
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transducers and activators of the transcription (STAT) signaling
pathway, which leads to synthesis of IFN-stimulated genes (ISGs).
These ISGs then establish the antiviral state. During the course of
evolution, viruses have developed numerous strategies to coun-
teract IFN production and signaling pathways to ensure their
propagation in the host (Versteeg and Garcia-Sastre, 2010).
Infection with PRRSV results in poor type 1 IFN production both
in in vitro infected macrophages and infected pigs (Albina et al.,
1998; Lee et al., 2004). This low level of IFN induction is a process
of active suppression by virus since infection with a strong IFN-
inducer transmissible gastroenteritis coronavirus (TGEV) after
PRRSV infection could not elicit detectable IFN production
(Albina et al., 1998). The nsps of PRRSV inhibit IFN-dependent
transcription. Earlier, we reported that ﬁve different nsps (nsp1a,
nsp1b, nsp2, nsp4 and nsp11) can inhibit IFN-b gene transcription
(Beura et al., 2010). The nsp1a and nsp1b protein suppress both
IRF3 and NF-kB mediated IFN gene induction (Beura et al., 2010;
Chen et al., 2010; Song et al., 2010). The nsp1b also interferes
with IFN signaling speciﬁcally the JAK-STAT pathway (Chen et al.,
2010; Patel et al., 2010). PRRSV nsp2 interferes with NF-kB
signaling by deubiquitinating the ubiquitinated IkBa molecule
that is important for NF-kB activation (Sun et al., 2010).
After being exposed to PRRSV, the animals develop viremia,
which lasts for a month, but the virus can still be detected in certain
secondary lymphoid tissue up to 5 months after infection (Allende
et al., 2000; Wills et al., 2003). The level of various proinﬂammatory
cytokines, other important components of host innate immune
response besides IFN, are low compared to those induced by several
other respiratory swine pathogens (Van Reeth et al., 1999; van Reeth
and Nauwynck, 2000). The subsequent development of effector
components of adaptive immune response e.g., neutralizing anti-
bodies, antigen-speciﬁc T-cells are delayed (Lopez and Osorio, 2004).
A robust adaptive immune response is dependent on proper priming
of the innate immune response. Hence, the initial suboptimal innate
response is hypothesized to be responsible for the delayed and
defective development of adaptive immune response (Kimman
et al., 2009; Murtaugh et al., 2002). Thus, a PRRSV that does not
efﬁciently suppress type 1 IFN induction is predicted to stimulate a
strong adaptive immune response culminating in the rapid clear-
ance of PRSSV (Nan et al., 2012).
The objective in this study was to map the domains/residues of
PRRSV nsp1a and nsp1b that are responsible for inhibiting IRF3
mediated gene induction. Using alanine-scanning mutagenesis,
we have identiﬁed such residues in both proteins. We were also
able to recover a virus with mutations in the nsp1b protein.
Characterization of the nsp1bmutant virus (16-5A) demonstrated
that the virus is attenuated for growth and induced higher level of
type 1 IFN in vitro. However, the mutation was unstable in vivo
and the revertant virus quickly regained the ability to suppress
IFN production in infected pigs.Results
Identiﬁcation of residues in PCPa domain of PRRSV nsp1a those are
important for inhibiting IFN production
Previously others and we have demonstrated that PRRSV
nsp1a is an inhibitor of IFN-b induction (Beura et al., 2010;
Chen et al., 2010). The current experiments are intended to map
the residues/domains of nsp1a involved in suppressing IFN
production. Alanine substitutions (3 aa to 5 aa) were made in
both N-terminal zinc ﬁnger domain (1–65 aa) and the PCPa
domain (66–166 aa) (Sun et al., 2009) of nsp1a. These alanine
scanning mutants are designated by the aa residue number of theﬁrst aa, followed by the number of residues mutated to alanine
e.g., mutant 10-5A has aa residue number 10 to 14 substituted by
alanine. It is possible that, these substitutions might affect correct
processing of the nsp1a–nsp1b junction by nsp1a protease,
which is important for virus viability. To ensure correct proces-
sing of this junction, these single amino acid substitutions were
made in the background of a full-length nsp1 expression plasmid
in which the nsp1b protein has been rendered inactive for ISG56
promoter inhibition. They were ﬁrst checked for successful
cleavage of the nsp1a–nsp1b junction and then subjected to
ISG56 reporter assay. The ISG56 reporter vector contains tandem
repeats of IFN-stimulated response element (ISRE) promoter
elements, which can be activated by IRF3/IRF7. ISG56 reporter
assay of these mutants showed that mutants (89-5A, 93-3A, and
97-4A) involving amino acid residues 89 to 100 are relieved of
their IFN-suppression property (Fig. 1A). However residue 96 was
not part of these mutants. None of the mutants in the N-terminal
zinc ﬁnger domain were able to relieve the IFN-suppression. Four
single amino acid substitution mutants of nsp1a (G90S, L91A,
N92A and R97A) in the 89 aa to 100 aa region showed almost
complete relief of the inhibitory effect (Fig. 1B).
Since several viral proteases that down regulate IFN produc-
tion can degrade certain signaling intermediates in the IFN
induction pathway (Li et al., 2005a, 2005b), it is possible that
nsp1a’s IFN suppression activity is mediated through its protease
activity. The exact protease active sites of the proteins were
determined on the basis of pairwise sequence alignment of the
FL12 strain (used in this study) to that of Lelystad strain (Kroese
et al., 2008).To examine whether nsp1a proteolytic activity is
essential for its IFN-antagonism, we generated mutants contain-
ing alanine substitution of nsp1a protease active site residue
His146. This mutant did not alter nsp1a’s IFN-suppression ability
(Fig. 1C). Thus, our mutational studies identiﬁed four speciﬁc
amino acids of PRRSV nsp1a responsible for its IFN-antagonism.
Several amino acid stretches of nsp1b are involved in its
IFN-suppression function
Our subsequent experiments were intended to map the
residues/domains of nsp1b involved in suppressing IFN produc-
tion. Initially, six mutants of nsp1bs were made; each with 30 aa
block deletions, and their ability to reduce the IFN-suppression
was analyzed by ISG56 reporter assay. To our surprise, all
mutants completely relieved the IFN-inhibitory property of wt
nsp1b (data not shown). This suggested that the 30 aa block
deletions of nsp1b might results in gross deformations in the
protein tertiary structure which likely results in nonfunctional
protein and thus having no effect on ISG56 promoter. Therefore,
we decided to perform alanine-scanning mutagenesis where
short amino acid stretches (5–7 aa) of wt nsp1b were replaced
by alanine. The crystal structure of PRRSV nsp1b was solved and
the protein has been found to possess three distinct domains: the
N-terminal nuclease domain (1 aa to 48 aa), the linker domain
(49 aa to 84 aa) and the C-terminal cysteine protease domain
(85 aa to 181 aa) (Xue et al., 2010). All the three domains were
targeted for mutagenesis and most of the residues mutated are
well conserved among type II PRRSV strains. The resulting 15
different mutants were then tested for protein expression and
their ability to suppress ISG56 promoter activity. There were wide
variations in the protein expression level of the different mutant
nsp1b relative to wt nsp1b in transient transfection assays, with
some mutants exhibiting higher levels of protein accumulation,
while others showing lower levels than wt nsp1b (Fig. 2A bot-
tom). The ISG56 reporter assay results showed variable degree of
alleviation in the IFN-suppression effect, with the highest exhibit-
ing 60% relief (Fig. 2A top).
Fig. 1. Mutant nsp1awith reduced ability to antagonize IRF3 mediated gene induction. ISG56 luciferase assay was performed with nsp1a alanine scanning mutant (A),
nsp1a single amino acid substitution mutant (B) and nsp1a protease active mutant (C). HEK-293TLR3 cells were co-transfected with indicated nsp1a mutant/wt
expression plasmids (1 mg) or empty vector (vector), ISG56-Luciferase plasmid (0.4 mg), and pRLTK (0.01 mg). At 40 h post-transfection, cells were treated with 5 mg/ml
dsRNA for 6 h and assayed for luciferase activity. The panel below the bar graph shows the protein expression of respective mutant nsp1a detected using anti-FLAG
antibody. Bars represent average (n¼3) relative ISG56 promoter activities compared to vector control (converted to 100%). Mutants whose ISG56 promoter activities are
signiﬁcantly different from wt nsp1a are indicated with an asterisk ‘n’ (po0.05). Beta-actin served as loading control.
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proteolytic processing of the nsp1b–nsp2 junction, which leads to
the release of nsp1b from the polyprotein. To examine whether
nsp1b proteolytic activity is essential for its IFN-antagonism, we
generated mutants of nsp1b with the individual protease active
sites mutated to alanine (C90A and H159A). When tested for their
IFN-inhibitory property in an ISG56-luc assay, these mutants
showed similar or even stronger suppression of the ISG56
promoter as measured by response to dsRNA stimulation
(Fig. 2B). We conclude that the protease active sites of nsp1b
are not critical for down regulation of IFN induction. Taken
together, we identiﬁed several mutant nsp1b with mutations
located in all the three domains with reduced ability to suppress
induction of an IRF3 dependent promoter in response to dsRNA
treatment.
Recovery of PRRSV harboring mutant nsp1b
From the alanine-scanning mutagenesis experiments described
above, we identiﬁed several mutant nsp1a and nsp1b proteins whichexhibit reduced ability to suppress IFN induction in response to
dsRNA. Our next objective was to recover viruses encoding these
mutant proteins. In the present study, we focused on mutants of
nsp1b rather than nsp1a, as the IFN promoter suppression exhibited
by nsp1a mutants is less potent than nsp1b. Speciﬁcally, we
concentrated on the N-terminal nuclease domain of PRRSV nsp1b
as certain viral nucleases have been shown to prevent induction of
type I IFN (Matzener et al., 2009) in a nuclease dependent manner. Of
the ﬁve nsp1b nuclease domain mutants (10-6A, 16-5A, 21-7A, 32-7A
and 48-6A) generated earlier, the ﬁrst three were chosen for pre-
paring virus since they not only showed higher alleviation in
IFN-inhibition but also have comparable level of protein expression
to the wild type (wt) nsp1b. We used standard reverse genetics
approach to recover these mutant viruses as described earlier (Kwon
et al., 2006; Truong et al., 2004). At 48 h post-electroporation of full
length infectious RNA, MARC-145 cells were immunostained for viral
nucleocapsid protein (indicator of sg mRNA transcription) as well as
viral nsp2/3 protein (indicator of viral replication). Of the three
different mutants we attempted for rescue, we were only able to
recover one virus containing the nsp1b 16-5A. The other two viruses
Fig. 2. Mutant nsp1b with reduced ability to antagonize IRF3 mediated gene induction. ISG56 luciferase assay was performed with nsp1b alanine scanning mutant
(A) and nsp1b protease active site mutants (B). HEK-293TLR3 cells were co-transfected with indicated nsp1bmutant expression plasmids (0.5 mg) or empty vector (vector),
ISG56-luciferase plasmid (0.4 mg), and pRLTK (0.01 mg). At 40 h post-transfection, cells were treated with 5 mg/ml dsRNA for 6 h and assayed for luciferase activity. The
panel below the bar graph shows the protein expression of respective mutant nsp1b detected using anti-FLAG antibody. Bars represent average (n¼3) relative ISG56
promoter activities compared to vector control (converted to100%). Mutants whose ISG56 promoter activities are signiﬁcantly different from wt nsp1b are indicated with
an asterisk ‘n’ (po0.05). Beta-actin served as loading control.
Fig. 3. Characterization of 16-5A mutant virus in vitro. (A) Hela cells were transfected with FLAG-tagged wt nsp1b or 16-5A mutant expression plasmid. Nsp1b’s
(in green) localization was determined 24 h post-transfection by indirect immunoﬂuorescence using anti-FLAG antibody. Position of nucleus is indicated by DAPI
(4,6-diamidino-2-phenylindole) (blue) by staining in the merge image (right). (B) Multiple step growth kinetics of 16-5A virus in comparison to parental wt virus.
Monocyte-derived macrophages were infected with 0.1 MOI of both viruses and culture supernatant were collected at indicated time post-infection. They were titrated
in MARC-145 cells and titers are expressed in Log10TCID50/ml. Error bars indicate SEM values derived from three independent experiments (‘
n’ indicates po0.05).
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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by absence of nsp2/3 and nucleocapsid protein staining by immuno-
ﬂuorescence (data not shown).
In vitro characterization of 16-5A mutant virus
As alteration in protein localization can affect protein func-
tion, we checked the localization of nsp1b 16-5A upon transient
transfection in HeLa cells (Fig. 3A). Both wt and mutant nsp1b
displayed similar nuclear and cytoplasmic localization as
described before (Chen et al., 2010). Next, we compared thein vitro growth characteristics of 16-5A mutant virus with that of
the parental wt PRRSV strain (FL12) in monocyte-derived macro-
phages. Although the multistep growth kinetics of both viruses
appeared similar, the mutant virus grew to titers that were on
average more than one log lower compared to the wt virus
(Fig. 3B). Such reduction in titer was evident at most of the time
points examined. Similar growth attenuation was also observed in
the permissive monkey kidney cell line MARC-145 (data not
shown). Taken together, these studies show that 16-5A mutant
virus was growth attenuated in vitro and the mutation did not
alter the natural localization of nsp1b.
Fig. 4. The 16-5A mutant induces higher level of type I IFN mRNAs. Porcine monocyte- derived macrophages were mock-infected/infected with 1 MOI of 16-5A mutant
or wt FL12 virus. Total RNA isolated from cells was reverse transcribed and real time PCR was done for detection of porcine IFN-a (A), IFN-b (B) mRNA. The mRNA copy
numbers were calculated after normalization with porcine b-actin copy number and expressed relative to mock control. Bars show average of mRNA copy numbers7SEM
from three independent experiments (‘n’ indicates po0.05). (C) MARC-145 cells infected with 16-5A/wt virus and 12 h post-infection were super-infected with sendai
virus (SeV) 50 HA (hemagglutinating) Units/ml to induce IFN synthesis for another 12 h. ISG56 protein level was detected by immunoblotting. The b-actin served as
loading control.
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in monocyte-derived macrophages
Our next objective was to investigate whether this mutant
PRRSV can induce higher levels of type 1 IFNs compared to the wt
virus. To this end, monocyte-derived macrophages were mock-
infected or infected with 1 MOI of wt PRRSV or 16-5A mutant
virus. Total RNA was isolated from the cells and porcine IFN-a and
IFN-b mRNA copy numbers were determined by real-time PCR.
Both types of IFNs were induced at signiﬁcantly higher levels in
16-5A virus infected macrophages compared to the wt virus at all
the three different time points tested (Fig. 4A and B). Following
IFN synthesis, it up-regulates production of hundreds of ISG and
ISG56 is one of them. Therefore, we checked ISG56 protein levels
in MARC-145 cells infected with wt or 16-5A mutant virus. A
moderate increase in ISG56 level in mutant virus-infected cells
compared to wt virus-infected cells (Fig. 4C) was observed. This
indicates that the 16-5A mutant virus exhibits reduced ability to
suppress IFN induction compared to the wt PRRSV.
The 16-5A mutant virus exhibits delayed growth characteristics and
is unstable in infected pigs
We then pursued in vivo characterization of the 16-5A mutant
virus and compared that to the parental virus (wt FL12). Two
groups of speciﬁc pathogen free young pigs (n¼4 each) were
infected with either wt or mutant virus. The level of viremia was
measured by determining the viral RNA copy numbers in sera at
different times post-infection. Animals infected with 16-5A virus
showed reduced viremia when compared to wt virus infected
animals during early time post-infection (3 dpi) (Fig. 5A). How-
ever, at later times, e.g., 5 dpi and 7 dpi, the difference between
the mutant and the wt virus was insigniﬁcant. Such rapid
recovery in growth of 16-5A mutant virus led us to hypothesize
that the mutant virus might have accumulated certain mutations
enabling it to attain growth properties similar to the wt PRSSV. To
examine this, we sequenced the nsp1b region of virus from serum
of 16-5A infected animals at 3 dpi, 7 dpi and 14 dpi. We observed
an alanine to threonine substitution at amino acid position 18 of
nsp1b at 3 dpi in all 16-5A infected animals (Fig. 5B). These
animals also accumulated another mutation at 7 dpi, in which
alanine at position 19 reverted to valine, which is the parental
amino acid at that position. At 14 dpi, both mutations were still
present and no other mutations were observed in nsp1b amino
acid sequence. This led us to investigate whether the resulting
revertant nsp1b (nsp1b TV mut) could relieve IFN suppression. AnISG56-luciferase based assay with the nsp1b TV mut showed that
it has similar IFN-suppression ability as the wt nsp1b and did not
offer any relief from suppression unlike 16-5A mutant (Fig. 5C).
The results suggest that the rapid growth recovery of the mutant
virus was mediated through the mutations in the 18 aa and 19 aa
positions of nsp1b 16-5A, which led to the regaining of nsp1b’s
IFN-suppressive ability.Discussion
Most of the research performed so far in relation to nsp1’s
anti-IFN activity includes protein overexpression. Such overex-
pression might lead to atypical expression, unusual localization of
protein leading to artifactual functions. In response to such
concern, we approached the question of whether nsp1 will act
as an IFN-antagonist in the context of virus infection. To this end,
the traditional method would call for development of a virus
without the IFN antagonistic property followed by checking the
relief in IFN suppression. However, since both nsp1a and nsp1b
are required for viral sg mRNA synthesis and processing of
polyprotein (two crucial steps in viral life cycle), it is impossible
to completely remove them from the viral genome (Kroese et al.,
2008). Therefore, we performed alanine-scanning mutagenesis to
map the residues involved in IFN-suppression. This approach was
predicted to have a better chance of recovering mutant viruses
that can replicate. We identiﬁed several discontinuous stretches
of nsp1b encompassing all the three domains as being responsible
for the inhibition of IRF3 mediated gene induction. It is possible
that different stretches might target distinct steps in the IFN
signaling pathway, a circumstance, which could not be distin-
guished by our end point ISG56 luciferase assay. Interestingly,
none of the alanine mutants could provide complete relief in the
suppression when expressed individually (Fig. 2A). This suggests
that multiple regions of nsp1b are needed for inhibiting IFN
production. Since these alanine mutants did not cover the whole
nsp1b sequence, the presence of other regions (not included in
our assay) with anti-IFN activity cannot be ruled out at this time.
Unlike nsp1b, we could more precisely locate (at the single amino
acid level) the IFN-antagonism in nsp1a. The three nsp1a
mutants G90S, N91A and L92A which are consecutively located
exhibited complete relief of inhibition of IRF3 gene induction. All
the three amino acids are important for nsp1a homodimer
interaction with N91 present on the surface of the protein
according the newly described nsp1a crystal structure (Sun
et al., 2009). It is therefore possible that nsp1a homodimerization
Fig. 5. Growth attenuation and instability of 16-5A virus in vivo. (A) The in vivo growth property of 16-5A virus. Wt FL12 or 16-5A mutant viruses were inoculated into
growing pigs and serum was collected at indicated days post-infection. After isolation of total RNA from serum, 4 ml of RNA was used in a single step real-time PCR reaction
to detect viral RNA copy numbers. The bars represent mean of the viral RNA copy number from 4 different animals in each group. Error bars indicate SEM values. (n indicate
po0.05 and ns is not signiﬁcant). (B) Mutations in the nsp1b in 16-5A infected pigs. The nsp1b region was ampliﬁed by reverse transcription PCR from the serum of 16-5A
mutant virus infected pigs at indicated days post-infection (dpi). The amino acid sequences from number 16 to 20 of nsp1b of different dpi were aligned. The 0 dpi
indicates the inoculated mutant sequence and dot (.) indicates no change in amino acid. The wt nsp1b sequence is mentioned in bottom for comparison. (C) ISG56
luciferase assay to determine the level of suppression of IRF3 dependent activation by nsp1b wt and nsp1b TVmut. Luciferase assay was performed and the results are
presented as mentioned earlier (‘n’ indicates po0.05).
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and nsp1b are cysteine proteases and their protease activity is
essential for correct processing of the viral polyprotein. Mutation
of the protease active site residues did not affect their anti-IFN
function. This observation is in line with the previous ﬁndings
that both proteases are only capable of cis-proteolytic activity
(cleaving themselves from the viral polyprotein) and once
released from the polyprotein, cease at being active as proteases
(Sun et al., 2009; Xue et al., 2010). Contrary to this view, Shi et al.
(2011) have reported that mutation of the nsp1a protease active
site resulted in loss of its anti-IFN property. Such discordance
might be explained by the use of the nsp1 full length plasmid in
the assay, as mutation of the cys76 (nsp1a protease active
residue) in this construct will prevent the processing of mature
nsp1a and nsp1b which might be important for IFN inhibition. An
alternative explanation would be that the amino acids used for
this substitution (serine for cysteine and tyrosine for histidine)
might affect the normal protein structure compared to our
alanine substitutions. Interestingly, a recent report from our
laboratory also implicates some of the same amino acids as found
in this study to being involved in interfering with TNFa mRNA
synthesis (Subramaniam et al., 2012).
Our efforts to recover viruses with mutations in nsp1b nucle-
ase domain had limited success. We could recover only one
mutant virus in nsp1b (16-5A). It is possible that these IFN-
antagonist deﬁcient viruses became susceptible to anti-viral
action of IFN that is produced by transfection of the in vitro
transcript during the virus recovery process. These transcripts
possess the 50 triphosphate group, which is a strong inducer of
RIG-I signaling (Schlee et al., 2009). To avoid such endogenous IFN
induction, we used BHK-21 cells that have impaired RIG-I signal-
ing (Habjan et al., 2008). However, when we repeated thetransfection experiments in BHK-21 cells we could only recover
the above-mentioned virus. There was no evidence of genome
replication (nsp2/3 immunoﬂuorescence staining) or sg mRNA
synthesis (nucleocapsid immunoﬂuorescence staining) in the case
of any of the remaining constructs. Besides their role in sg RNA
transcription, PRRSV nsp1a and nsp1b are involved in viral
polyprotein processing. So to check for the proper protein
cleavage, we transferred the nsp1b 10-6A and 21-7A mutations
(the non-recoverable viruses) to full-length nsp1. Both the
mutants showed reduced processing of nsp1 polyprotein, corro-
borating that proper nsp1 cleavage is essential for viral replica-
tion (data not shown).
Several studies have indicated that IFN antagonist knockout
viruses exhibit severe growth defects in vitro and are promptly
cleared in vivo by the host IFN response (Richt and Garcia-Sastre,
2009). In this report, we have pursued characterization of one of
the nsp1b mutant virus (16-5A). The virus exhibits slow growth
kinetics in monocyte-derived macrophages and was able to attain
a maximal titer of 104 TCID50/ml. Such growth ability of 16-5A
might be due to the residual IFN suppression activity of the virus
encoded by four other fully functional IFN antagonistic nsps
previously described (Beura et al., 2010). The 16-5A mutant virus
showed delayed growth kinetics in vivo but eventually reached
titers equivalent to wt PRRSV at 7 dpi. This abnormal in vivo
kinetics of growth was due to the reversion of the 16-5A
mutation, as the revertant nsp1b obtained from the revertant
virus showed equally effective IFN-suppression as wt nsp1b. This
gain-of-function mutation most likely contributed to 16-5A virus’
ability to attain wt growth. It is possible that a minor species of
virus with the mutation(s) may have appeared during our routine
passage in cell culture (to prepare stocks for inoculation). How-
ever our sequencing control (standard Sanger sequencing) of the
L.K. Beura et al. / Virology 433 (2012) 431–439 437inoculant virus did not give any such indication. Nevertheless this
indicates a strong selective pressure on these residues during
growth inside the host. Interestingly, the ﬁrst residue to be
replaced is alanine at position 18 by a polar residue (threonine)
(at 3 dpi). The natural amino acid at this position is lysine, which
has been implicated in nsp1b’s nuclease activity. Xue et al. (2010)
have suggested that lysine18 is responsible for stabilizing the
bound nucleic acid in the positively charged pocket formed in the
nuclease domain of nsp1b. But presence of threonine at this
position in the recovered TV mut virus indicates that the presence
of a polar residue might be is essential for a functional nuclease
activity, which in turn might be important for efﬁcient in vivo
viral replication. Alternatively, the nuclease activity of nsp1b is
not required for virus multiplication. Mutation of lysine18 to
alanine alone was not sufﬁcient to alleviate nsp1b’s IFN-
suppression ability (in ISG56 luciferase assay), which suggests
that nuclease activity is probably not important for IRF3-
dependent IFN modulation (data not shown). It should be noted,
however, that a possible role of the nuclease activity in other
transcription factor mediated IFN induction cannot be excluded.
PRRSV nsp1’s innate immune antagonistic action has attracted
considerable attention in recent years resulting in research that
has enhanced our understanding of the biological role of this
protein. The known mechanisms of IFN-suppression by nsp1a
include inhibition of IkB phosphorylation which prevents nuclear
translocation of NF-kB (Song et al., 2010). Nsp1b’s mode of action
includes both inhibition of IRF3 phosphorylation and nuclear
translocation, as well as inhibition of STAT1/STAT2 nuclear
translocation (Beura et al., 2010; Chen et al., 2010; Patel et al.,
2010). In addition, Kim et al. (2010) has shown that expression of
nsp1 can target CREB-binding protein (CBP) for proteasomal
degradation. However the precise mechanisms regarding how
nsp1 achieves these multiple functions need to be identiﬁed and
will be important for exact mapping of the residues involved in
IFN down regulation.
In summary, our results conﬁrm the IFN-inhibitory nature of
PRRSV nsp1 in the context of virus infection. Alanine-scanning
mutagenesis identiﬁed amino acids important for the anti-IFN
property of both proteins nsp1a and nsp1b. A mutant virus,
which induces signiﬁcantly higher level of IFN mRNA in vitro
quickly, reverted in vivo to acquire the IFN-suppression ability.
Future studies should then include a more thorough scanning of
the viral proteins to identify residues involved in IFN antagonism.
Such mutational studies will likely be especially challenging in
case of PRRSV as it would target multiple nsps, most of which are
essential for viral replicative cycle. Inclusion of an in vitro
replication-transcription assay along with IFN-related assay will
help to segregate the IFN-inhibitory domains from replicative
domains of the proteins and accelerate the ﬁnding of successful
candidate mutations. There are ample examples of viruses with
rationally designed modiﬁcations to remove the anti-IFN property
without alteration in their replication potential. Information from
such studies can be incorporated to develop effective control
strategies against PRRSV (Yoo et al., 2010).Materials and methods
Cells and viruses
MARC-145 (obtained from Dr. Will Laegreid, USMARC, USDA/ARS)
(Kim et al., 1993) and HEK293-TLR3 (Invivogen) cells were main-
tained in DMEM containing 10% fetal bovine serum and 50 mg/ml of
gentamicin (Sigma). Porcine monocyte-derived macrophages were
prepared from peripheral blood mononuclear cells as described
previously (Loving et al., 2007). Brieﬂy, mononuclear cells wereisolated from blood of donor pigs by Ficoll density centrifugation
using Lymphocyte separation medium (Mediatech). These cells were
allowed to attach to a glass petridish for one day followed by washing
with PBS to enrich the monocytes. The attached monocytes were
cultured in RPMI 1640 medium supplemented with 10% BVDV-free
fetal bovine serum in presence of macrophage colony stimulating
factor (5 ng/ml) (Sigma) for 7 day in order to induce their differentia-
tion into macrophages. These monocyte-derived macrophages were
then harvested by cell dissociation buffer (Gibco) and seeded with
RPMI 1640 and 10% FBS for virus infection.
Infectious clone derived genotype II PRRSV strain FL12 (Truong
et al., 2004) was propagated in MARC-145 cells to prepare the
virus stocks for this study. The various mutant viruses were also
propagated in MARC-145 cells upon recovery. Viruses from
passage 3 (P3) were used for most in vitro experiments as well
as for animal inoculation. Sendai virus (Cantell strain) was
obtained from Charles River Laboratories and was used at 50
haemagglutinating unit/ml concentration for infection of MARC-
145 cells.
Plasmids and antibodies
The pIHA-FLAG-nsp1a, pIHA-FLAG-nsp1b, pISG56-luc plasmids
have been described earlier (Beura et al., 2010; Subramaniam
et al., 2010). The nsp1b block deletion mutants were prepared by
overlap extension PCR method. The different alanine substitution
mutants have been described (Subramaniam et al., 2012) and
were prepared by site-directed mutagenesis by megaprimer PCR
method (Sarkar and Sommer, 1990). All the mutant constructs
have a N-terminal FLAG tag.
Antibodies used in this study and their sources are as
follows—SDOW 17 (anti-PRRSV N monoclonal antibody) (Nelson
et al., 1993) was purchased from National Veterinary Services
Laboratories (NVSL, Ames, IA). The mouse anti-b-Actin (Sc-47778)
was obtained from Santa Cruz Biotech. The anti-Flag M2 (F3165)
and rabbit anti-FLAG (F7425) were products of Sigma Aldrich.
Secondary antibodies conjugated to HRP were purchased from
Kirkegaard and Perry Ltd (KPL) including goat anti-mouse (074-
1807) and goat anti-rabbit (214-1516) antibodies. PRRSV nsp1
antibody was developed by immunizing rabbit with the protein
and could detect both nsp1a and nsp1b. The anti-ISG56 and anti-
nsp2/3 antibodies were generous gifts from Dr. Saumendra
Sarkar, U Pittsburg and Dr. Eric J. Snijder, LUMC, The Netherlands,
respectively.
Reporter assays
ISG56-luciferase reporter assays were performed as described
earlier with minor modiﬁcations (Beura et al., 2010). Brieﬂy,
HEK293-TLR3 cells were transfected with 0.4 mg of ISG56-
luciferase reporter plasmid and 20 ng of pRL-TK (Promega) along
with indicated protein expression vectors using TransIT (Mirus
Bio) as per manufacturer’s protocol. Twenty four hours post-
transfection the media was replaced with fresh media. At 40 h
post-transfection, cells were either treated with 5 mg/ml of poly
(I): poly (C) (GE Health Care) or PBS for 6 h and luciferase assays
were performed using Dual Luciferase assay kit from Promega.
Then the ﬁreﬂy luciferase activities were expressed as percen-
tages with respect to control after normalizing with renilla
luciferase activities (empty vector transfected and dsRNA stimu-
lated cells, were normalized to 100%).
IFN and viral RNA real-time PCR
For IFN real-time PCR, total RNA was isolated from virus
infected/mock-infected monocyte-derived macrophages using
L.K. Beura et al. / Virology 433 (2012) 431–439438Trizol (Invitrogen) reagent and was treated with DNase before
cDNA synthesis. Then 1 mg of RNA was reverse transcribed using
oligo-dT primer and the M-MLV reverse transcription kit (Invitro-
gen) as per manufacturer’s recommendation. Next the cDNA was
used for real-time PCR to quantitate the indicated mRNA copy
number in a Smartcycler machine (Cepheid) using the Faststart
Universal Probe Mastermix (Roche). The cycling conditions used
were – initial denaturation 95 1C/10 min, ampliﬁcation
(40 cycles) – 95 1C/30 s and 60 1C/30 s. The swine IFN-a, b and
b-actin (internal control) real time PCR was performed using a
TaqMan probe based method as described earlier (Beura et al.,
2010). IFN-a and IFN-b mRNA levels in virus-infected cells were
expressed in copy numbers relative to mock-infected cells as per
the method described earlier (Stordeur et al., 2002). The IFN
mRNA levels were normalized across the experiments using
porcine b-actin as internal control. For measuring viral RNA copy
numbers a single step Taqman-based reverse transcription-real
time PCR using Hot start-IT Probe one step qRT-PCR master mix
(Affymetrix) was designed. Viral RNA was isolated using Qiagen
Viral RNA mini kit (Qiagen) from 140 ml of serum from infected
pigs following manufacturer’s instruction. The isolated RNA (4 ml)
was used in the PCR reaction and the RNA copy number was
calculated using a standard curve generated with in vitro tran-
scripts. The probe and primers used were—3UTR84P (probe)–
TCACCTATTCAATTAGGGCGACCG, 3UTR44F (forward primer)–
ATGTGTGGTGAATGGCACTG and 3UTR141R21 (reverse primer)–
GCATGGTTCTCGCCAATTAAA. The PCR is targeted to the 3’UTR of
type II PRRSV. The cycling conditions for this PCR were—reverse
transcription 50 1C/30 min, initial denaturation 95 1C/2 min,
ampliﬁcation 45 cycles (95 1C/15 s and 60 1C/60 s).
Immunoblotting assay
In over-expression experiments, the indicated plasmids were
transfected into 293TLR3 cells using Lipofectamine2000 (Invitrogen)
or TransIT (Mirus Bio) as per manufacturer’s protocol. Then, 36 to
48 h after transfection, the cells were washed twice with PBS and
collected for lysate preparation. Lysis was performed in the lysis
buffer [20 mM Tris (pH7.5), 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-
glycerophosphate, 1 mM sodium orthovanadate and complete
protease inhibitor (Roche)]. After clariﬁcation at 13,000 RPM for
10 min at 4 1C, the lysates were resolved in SDS-PAGE followed by
transfer onto polyvinylidenediﬂuoride (PVDF) membrane (Milli-
pore). Then the membranes were blocked in blocking buffer (Tris
buffered saline containing 5% nonfat dry milk and 0.1% Tween 20)
for 1 h followed by incubation with indicated primary antibodies.
After that, membranes were washed and incubated with horse-
radish peroxidase (HRP)-conjugated secondary antibodies. Finally
the proteins were visualized with an ECL detection system
(Pierce).
In vitro transcription, RNA electroporation and mutant virus recovery
Generation of full length PRRSV in vitro transcripts have been
described earlier (Kwon et al., 2006; Truong et al., 2004). Brieﬂy
the mutant pFL12 full-length plasmids were linearized with AclI
restriction enzyme. The digested DNA was phenol: chloroform
puriﬁed and 1 mg of DNA was used as template in a 20 ml in vitro
transcription reaction using mMESSAGEmMACHINE ultra T7 kit
(Ambion) as per manufacturer’s recommendation. The resulting
capped and polyadenylated full length RNA was further puriﬁed
with phenol: chloroform before being used in the electroporation
reaction. MARC-145 cells were electroporated as described pre-
viously (Kwon et al., 2006; Truong et al., 2004). After electro-
poration, cells were seeded in DMEM media containing 10% FBS.Cells were regularly checked for development of cytopathic effect
and virus growth was also conﬁrmed by indirect immunoﬂuor-
escence using anti-N and anti-nsp2/3 antibodies. Upon conﬁrma-
tion of virus growth, supernatants from the plates were collected
and clariﬁed. This supernatant was labeled as passage ‘0’ (P0) and
was further ampliﬁed to prepare stocks for subsequent studies.
Viral growth kinetics
For multiple step growth curve, monocyte-derived macro-
phages were infected at 0.1 multiplicity of infection (moi) with
indicated viruses. Then culture supernatants were collected at
indicated time post viral infection and were stored at 80 1C
until titration. Titrations of the supernatants were performed in
MARC-145 cells and expressed as tissue culture infectious dose 50
per ml (TCID50/ml) as per Spearman and Karber method.
Animal experiments
All animal studies were performed according to the protocols
approved by the Institutional Animal Care and Use Committee at
the University of Nebraska-Lincoln. Four to six-week old pigs
(n¼8) were purchased from a speciﬁc pathogen-free herd with a
certiﬁed record of PRRSV absence. Pigs were randomly divided
into two groups (n¼4) and inoculated with 105.2 TCID50/ml
(in total of 2 ml inoculum) of the FL12 (wt PRRSV) or 16-5A virus.
The inoculum was divided equally and inoculated through both
intramuscular as well as intranasal route. Viremia was measured
by real-time PCR in sera collected at 3, 7 and 14 day post-
infection (dpi).Acknowledgments
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